ABT vs. ISRG, BSX, SYK, MDT, BDX, EW, IDXX, DXCM, RMD, and STE
Should you be buying Abbott Laboratories stock or one of its competitors? The main competitors of Abbott Laboratories include Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), DexCom (DXCM), ResMed (RMD), and STERIS (STE). These companies are all part of the "health care equipment" industry.
Abbott Laboratories vs.
Intuitive Surgical (NASDAQ:ISRG) and Abbott Laboratories (NYSE:ABT) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.
In the previous week, Abbott Laboratories had 23 more articles in the media than Intuitive Surgical. MarketBeat recorded 72 mentions for Abbott Laboratories and 49 mentions for Intuitive Surgical. Abbott Laboratories' average media sentiment score of 1.56 beat Intuitive Surgical's score of 1.35 indicating that Abbott Laboratories is being referred to more favorably in the news media.
Intuitive Surgical has a beta of 1.39, meaning that its stock price is 39% more volatile than the S&P 500. Comparatively, Abbott Laboratories has a beta of 0.75, meaning that its stock price is 25% less volatile than the S&P 500.
83.6% of Intuitive Surgical shares are owned by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are owned by institutional investors. 0.9% of Intuitive Surgical shares are owned by company insiders. Comparatively, 1.1% of Abbott Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Intuitive Surgical currently has a consensus price target of $613.10, indicating a potential upside of 3.60%. Abbott Laboratories has a consensus price target of $133.06, indicating a potential downside of 1.46%. Given Intuitive Surgical's higher possible upside, equities analysts clearly believe Intuitive Surgical is more favorable than Abbott Laboratories.
Abbott Laboratories has higher revenue and earnings than Intuitive Surgical. Abbott Laboratories is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.
Abbott Laboratories has a net margin of 31.95% compared to Intuitive Surgical's net margin of 27.81%. Abbott Laboratories' return on equity of 20.74% beat Intuitive Surgical's return on equity.
Intuitive Surgical received 108 more outperform votes than Abbott Laboratories when rated by MarketBeat users. However, 69.90% of users gave Abbott Laboratories an outperform vote while only 68.87% of users gave Intuitive Surgical an outperform vote.
Summary
Abbott Laboratories beats Intuitive Surgical on 11 of the 19 factors compared between the two stocks.
Get Abbott Laboratories News Delivered to You Automatically
Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Abbott Laboratories Competitors List
Related Companies and Tools
This page (NYSE:ABT) was last updated on 2/21/2025 by MarketBeat.com Staff
